0
0
In a significant step to improve transparency, patient safety, and affordability of healthcare in its public hospitals, Haryana has issued strict directives mandating doctors in government hospitals to prescribe medicines using only generic names and requiring all hospital staff to wear name tags while on duty. These measures, released by the Haryana State Health Resource Center (HSHRC) in late 2025, follow inspections revealing continued prescription of branded drugs and lack of proper identification of healthcare personnel in government facilities.
Key Developments and Directives
HSHRC’s circular mandates that every prescription in government hospitals must include the doctor’s full name, designation, registration number, official stamp, and signature, and be written exclusively in generic drug names. This policy aims to ensure that prescriptions are legible, traceable, and unambiguous to both patients and pharmacists. Dr Virender Yadav, Executive Director of HSHRC, emphasized the urgency of this policy by stating, “Every outpatient slip and lab request must be legible and traceable,” with immediate implementation now underway.
Alongside prescription reforms, a separate directive requires all hospital staff to wear visible name tags with appropriate prefixes (such as Dr., Mr., or Ms.), designation, and readable font size. The move targets greater accountability, identification, and professionalism in hospital settings where patients and visitors often face challenges interacting with unidentifiable personnel. Inspections found numerous staff without name badges, which HSHRC flagged as a lapse affecting patient trust and safety.
Legal and Policy Context
These directives align with a broader national push for the rational use of medicines and affordable healthcare spearheaded by the Union government and regulatory bodies. Generic drugs, which contain the same active ingredients as branded versions but at significantly lower cost, have long been promoted to improve access to essential medicines. The National Medical Commission (NMC) and Medical Council of India guidelines have recommended generic prescribing since 2016, yet enforcement has been inconsistent at the state level
A landmark ruling by the Punjab and Haryana High Court in August 2025 further reinforced the importance of legible and generic prescriptions by declaring the right to a clear medical prescription as fundamental under Article 21 of the Indian Constitution (right to life). The Court ordered that all doctors in both government and private sectors write prescriptions in clear, capital letters or move towards typed/digital formats until digital prescriptions are universally adopted. The Court noted that illegible prescriptions pose real dangers, including medication errors and compromised patient safety.
Expert Perspectives
Dr. Anjali Sharma, a public health expert unaffiliated with HSHRC, welcomed Haryana’s initiatives as vital steps toward reducing medication errors and improving patient trust in government healthcare. She remarked, “Generic prescribing not only cuts down healthcare costs for patients, but improved transparency through name tags and clear prescriptions enhances responsibility and communication between providers and patients”.
However, some healthcare professionals voice concerns over generic mandates. A report in the BMJ (British Medical Journal) in 2023 highlighted apprehensions from Indian doctors about mandatory generic prescriptions, citing quality control issues with some generic drugs and the need for assured drug efficacy before enforcement. The Indian Medical Association has urged caution, stressing patients’ right to quality care must not be compromised in the transition to generic prescribing.
Public Health Implications
Haryana’s directives serve multiple crucial public health goals: making treatment more affordable without compromising quality, fostering transparency in healthcare interactions, and reducing risks associated with illegible prescriptions. Clear prescriptions and visible identification can substantially reduce medication errors, enhance patient understanding and adherence, and support legal and ethical accountability.
For patients, this means cost savings from cheaper generic drugs and improved clarity about their treatment regimen, potentially decreasing adverse drug events or dispensing mistakes. For healthcare providers, it promotes discipline and standardizes prescribing practices in line with national and judicial expectations.
Limitations and Ongoing Challenges
Despite these positive steps, challenges remain. Enforcement outside government hospitals, especially in private clinics and pharmacies, varies widely. Some generic drugs face skepticism due to perceived variable quality, which regulatory bodies must address to maintain patient confidence. Digital prescription systems, seen as the next evolution in safer prescribing, are yet to be widely implemented in Haryana and across India, delaying seamless adoption of these standards.
The need for continued education, both among healthcare workers and patients, on the benefits and safety of generic drugs is crucial. Furthermore, name tag compliance and prescription legibility require regular monitoring to ensure sustained impact.
Conclusion
Haryana’s policy mandating generic drug prescriptions and compulsory name tags in government hospitals marks a significant stride toward safer, more transparent, and affordable healthcare. Supported by the Punjab and Haryana High Court’s strong rulings and aligned with national health missions, these reforms promise better patient outcomes and trust. Ensuring robust drug quality, fostering digital prescription adoption, and maintaining vigilant enforcement will be key to realizing their full benefits.
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
